Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002734882 | SCV003000143 | benign | not provided | 2023-07-16 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002734882 | SCV004225614 | uncertain significance | not provided | 2021-11-22 | criteria provided, single submitter | clinical testing | PM2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004690317 | SCV005185549 | uncertain significance | not specified | 2024-05-06 | criteria provided, single submitter | clinical testing | Variant summary: SOX10 c.601G>A (p.Ala201Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.4e-05 in 1612016 control chromosomes. c.601G>A has been reported in the literature in at least one individual affected with hypogonadotropic hypogonadism and authors classified this variant as likely benign (Kallman syndrome) (e.g. Federici_2022). This report does not provide unequivocal conclusions about association of the variant with Waardenburg Syndrome Type 2E. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 36531499). ClinVar contains an entry for this variant (Variation ID: 1961580). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. |